Illumina, Inc. (ILMN)

220.00 +3.05 (+1.41%) At close: 04:00PM EDT

Illumina, Inc.

5200 Illumina Way
San Diego, CA 92122
United States
858 202 4500
https://www.illumina.com

Sector(s): Healthcare
Industry: Diagnostics & Research
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Francis A. deSouza	CEO & Director	N/A	N/A	1971
Dr. Alexander Aravanis M.D., Ph.D.	CTO & Head of Research and Product Devel.	1.05M	N/A	1977
Mr. Charles E. Dadswell	Sr. VP, Gen. Counsel & Sec.	N/A	N/A	1959
Ms. Susan H. Tousi	Chief Commercial Officer	1.04M	N/A	1969
Stephanie Campos	Pres	N/A	N/A	N/A
Dr. Joydeep Goswami M.B.A., Ph.D.	CFO, Chief Strategy & Corp. Devel. Officer	N/A	N/A	1971
Mr. Kevin Carl Pegels	Chief of Global Operations	N/A	N/A	N/A
Mr. Scott Ericksen	VP & Chief Accounting Officer	N/A	N/A	1972
Ms. Carissa Rollins	Chief Information Officer	N/A	N/A	N/A
Ms. Sallilyn Schwartz	VP of Investor Relations	N/A	N/A	N/A

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements, as well as cancer detection testing services. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. The company was incorporated in 1998 and is based in San Diego, California.

Corporate Governance

Illumina, Inc.’s ISS Governance QualityScore as of February 1, 2023 is 3. The pillar scores are Audit: 1; Board: 3; Shareholder Rights: 7; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.